High triglyceride, low HDL cholesterol, and risk of coronary artery disease;Højt triglycerid, lavt HDL-kolesterol og risiko for koronar hjertesygdom

Ugeskrift for Laeger

Volumn 158, Issue 48, 1996, Pages 6896-6901

  Jeppesen, Jørgen ^a   Madsbad, Sten ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

BLOOD; CORONARY ARTERY DISEASE; HUMAN; INSULIN RESISTANCE; REVIEW; RISK FACTOR;

CHOLESTEROL, HDL; CORONARY DISEASE; HUMANS; INSULIN RESISTANCE; RISK FACTORS; TRIGLYCERIDES;

EID: 0030601923     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Kannel WB, Wilson PWF. Efficacy of lipid profiles in prediction of coronary disease. Am Heart J 1992; 124: 768-74.
2. Pyörälä K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiological view. Diabetes Metab Rev 1987; 3: 463-524.
3. Garg A, Grundy SM. Management of dyslipidemia in NIDDM. Diabetes Care 1991; 13: 153-69.
4. Laakso M, Lehto S, Penttilä I, Pyörälä K. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 1993; 88: 1421-30.
5. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990; 263: 2893-8.
6. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK, Ferrannini E. Parental history of diabetes is associated with increased cardiovascular risk factors. Arteriosclerosis 1989; 9: 928-33.
7. Sarlund H, Pyörälä K, Penttilä I, Laakso M. Early abnormalities in coronary heart disease risk factors in relatives of subjects with non-insulin-dependent diabetes. Arterioscler Thromb 1992; 12: 657-63.
8. Laws A, Reaven GM. Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations. J Intern Med 1992; 231: 25-30.
9. Abbott WGH, Lillioja S, Young AA, Zawadzki JK, Yki-Järvinen H, Christin L et al. Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population. Diabetes 1987; 36: 897-904.
10. Laakso M, Sarlund H, Mykkänen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis 1990; 10: 223-32.
11. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
12. Wilson PWF, Anderson KM, Castelli WP, Kannel WB. Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: The Framingham Offspring Study. Am J Med 1991; 90: 11-6.
13. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 1991; 325: 373-81.
14. Bainton D, Miller NE, Bolton CH, Yarnell JWG, Sweetnam PM, Baker IA et al. Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Br Heart J 1992; 68: 60-6.
15. Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb 1991; 11: 2-14.
16. Castelli WP. Epidemiology of triglycerides: a view from Framingham. Am J Cardiol 1992; 70: 3-9H.
17. Assmann G, Schulte H. Triglycerides and atherosclerosis: results from the Prospective Cardiovascular Münster Study. Arterioscler Rev 1991; 22: 51-7.
18. Kinosian B, Glick H, Garland G. Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med 1994; 121: 641-7.
19. Assman G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol 1992; 70: 733-7.
20. Manninen V, Tenkanen L, Koskinen P, Huttunen JS, Mänttäri M, Heinonen OP et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study: implications for treatment Circulation 1992; 85: 37-45.
21. Bass KM, Newschaffer CJ, Klag MJ, Bush TL. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med 1993; 153: 2209-16.
22. Brunner D, Weisbort J, Meshulam N, Schwartz S, Gross J, Saltz-Rennert H et al. Relation of serum total cholesterol and high-density lipoprotein cholesterol percentage to the incidence of definite coronary events: twenty-year follow-up of the Donolo-Tel Aviv Prospective Coronary Artery Disease Study. Am J Cardiol 1987; 59: 1271-6.
23. Tobey TA, Greenfield M, Kraemer F, Reaven GM. Relationship between, insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normotriglyceridemic man. Metabolism 1981; 30: 165-71.
24. Karhapää P, Malkki M, Laakso M. Isolated low HDL cholesterol: an insulin-resistant state. Diabetes 1994; 43: 411-7.
25. Wayne H-HS, Shieh S-M, Fuh M, Shen D-C, Jeng C-Y, Chen Y-DI et al. Insulin resistance, glucose intolerance, and hyperinsulinemia. Hypertriglyceridemia versus hypercholesterolemia. Arterioscler Thromb 1993; 13: 367-70.
26. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini GM, Graziadei L et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-7.
27. Laws A, Stefanick ML, Reaven GM. Insulin resistance and hypertriglyceridemia in nondiabetic relatives of patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1989; 69: 343-7.
28. Ferrari P, Weidmann P, Shaw S, Giachino D, Riesen W, Allemann Y et al. Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. Am J Med 1991; 91: 589-96.
29. Facchini F, Chen Y-D, Clinkingbeard C, Jeppesen J, Reaven GM. Insulin resistance, hyperinsulinemia. and dyslipidemia in nonobese individuals with a family history of hypertension. Am J Hypertens 1992; 5: 694-9.
30. Beatty OL, Harper R, Sheridan B, Alkinson Ab, Bell PM. Insulin resistance in offspring of hypertensive parents. BMJ 1993; 307: 92-6.
31. Rosseneu M, Fruchart JC, Bard JM, Nicaud V, Vinaimont N, Cambien F et al. Plasma apolipoprotein concentrations in young adults with a parental history of premature coronary heart disease and in control subjects: The EARS Study. Circulation 1994; 89: 1967-73.
32. Denke MA, Sempos CT, Grundy SM. Excess body weight an underrecognized contributor to high blood cholesterol levels in white American men. Arch Intern Med 1993; 153: 1093-103.
33. Manson JE, Nathan DM, Krolewski AS, Stampfer MJ, Willett WC, Hennekens CH. A prospective study of exercise and incidence of diabetes among US male physicians. JAMA 1992; 268: 63-7.
34. Perry U, Wannamethee SG, Walker MK, Thomson AG, Whincup PH, Shaper AG. Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. BMJ 1995; 310: 560-4.
35. Hunt SC, Stephenson Sh, Hopkins PN, Williams RR. Predictors of an increased risk of future hypertension in Utah: a screening analysis. Hypertension 1991; 17: 969-76.
36. Facchini FS, Hollenbeck CB, Jeppesen J, Chen Y-DI, Reaven GM. Insulin resistance and cigarette smoking. Lancet 1992; 339: 1128-30.
37. Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ 1995; 310: 555-9.
38. Olefsky J, Reaven GM, Farquhar JW. Effects of weight reduction on obesity. Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects. J Clin Invest 1974; 53: 64-76.
39. RÜnnemaa T, Marniemi J, Puukka P, Kuusi T. Effects of long-term physical exercise on serum lipids, lipoproteins and lipid metabolizing enzymes in type 2 (non-insulin-dependent) diabetic patients. Diabetes Res 1988; 7: 79-84.
40. Su HY, Sheu WHH, Chin HML, Jeng CY, Y-DI Chen, Reaven GM. Effect of weight loss on blood pressure and insulin resistance in normotensive and hypertensive obese individuals. Am J Hypertens 1995; 8: 1067-71.